David Abood
Overview
Explore the profile of David Abood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angell C, Sun S, Lapurga G, Benner B, Quiroga D, Savardekar H, et al.
Melanoma Res
. 2025 Jan;
35(2):102-108.
PMID: 39883562
Myeloid-derived suppressor cells (MDSCs) are expanded in cancer patients, have an intrinsic immunosuppressive function, and thus may play a role in resistance to immunotherapy. Ulceration of the melanoma primary is...
2.
Sun S, Angell C, Savardekar H, Sundi D, Abood D, Benner B, et al.
Cancer Immunol Immunother
. 2023 Aug;
72(11):3461-3474.
PMID: 37528320
Myeloid-derived suppressor cells (MDSC) have been linked to loss of immune effector cell function through a variety of mechanisms such as the generation of reactive oxygen and nitrogen species and...
3.
Sun S, Benner B, Savardekar H, Lapurga G, Good L, Abood D, et al.
Front Immunol
. 2021 Oct;
12:740890.
PMID: 34712230
Introduction: Myeloid-derived suppressor cells (MDSC) are a subset of immature myeloid cells that inhibit anti-tumor immunity and contribute to immune therapy resistance. MDSC populations were measured in melanoma patients receiving...
4.
Pinette A, McMichael E, Courtney N, Duggan M, Benner B, Choueiry F, et al.
Cancer Immunol Immunother
. 2019 Jul;
68(8):1379-1389.
PMID: 31338557
Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide and epidermal growth factor receptor (EGFR) is overexpressed in greater than 90% of patient...
5.
Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace T, Benner B, et al.
Clin Cancer Res
. 2018 Jan;
24(8):1891-1904.
PMID: 29363526
mAbs are used to treat solid and hematologic malignancies and work in part through Fc receptors (FcRs) on natural killer cells (NK). However, FcR-mediated functions of NK cells from patients...
6.
Trikha P, Plews R, Stiff A, Gautam S, Hsu V, Abood D, et al.
Oncoimmunology
. 2016 Oct;
5(9):e1214787.
PMID: 27757311
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of early myeloid cells that accumulate in the blood and tumors of patients with cancer. MDSC play a critical role during tumor...